KCT0007708
Completed
未知
A randomized, double-blind, placebo-controlled trial to the efficacy of high-protein oral nutrition supplement (Nucare Active) improving muscle function
DAESANG Life Science Corporation0 sites70 target enrollmentTBD
ConditionsDiseases of the nervous system
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Diseases of the nervous system
- Sponsor
- DAESANG Life Science Corporation
- Enrollment
- 70
- Status
- Completed
- Last Updated
- 3 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\) Adult woman aged 50 to 80
- •2\) A person who voluntarily agrees to participate in the human body application test and signs an informed consent form
Exclusion Criteria
- •1\) A person with a BMI of 30\.0 kg/? or more
- •2\) A person whose blood sugar is not controlled even though they are taking medication: fasting blood sugar is 126 mg/dL or higher even though they are taking diabetes medication
- •3\) A person with hypertension whose blood pressure is not controlled even though they are taking medication: systolic blood pressure 160 mmHg or diastolic blood pressure 100 mmHg higher even though they are taking medication for hypertension
- •4\) A person with renal dysfunction (more than 1\.5 times higher than the normal upper limit of creatine) and liver dysfunction (2\.5 times higher than the normal upper limit of AST, ALT)
- •5\) A person with cognitive impairment (MMSE \< 24\) or mental illness
- •6\) A serious musculoskeletal problem
- •7\) When walking is impossible
- •8\) A person diagnosed with acute and serious diseases (hepatic, kidney, heart, thyroid disease, malignancy) or who is on medication
- •9\) A person who has continuously performed aerobics or resistance exercises within 6 months prior to the visit (resistance exercises: exercises aimed at improving muscle strength)
- •10\) A person who has continuously taken hormones, muscle strengthening agents, protein supplementation, improving muscle function, health functional food related to exercise performance within 3 months prior to the visit
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Not Applicable
Efficacy and safety study of DEB025/Alisporivir combined to Peg-IFN and Ribavirin in chronic hepatitis C genotype 1 naïve patients.Chronic Hepatitis C genotype 1 treatment-naïve patientsMedDRA version: 14.1Level: LLTClassification code 10008912Term: Chronic hepatitis CSystem Organ Class: 10021881 - Infections and infestationsTherapeutic area: Diseases [C] - Virus Diseases [C02]EUCTR2010-022867-37-DEovartis Pharma Services AG1,040
Recruiting
Phase 1
A randomized, double-blind, placebo-controlled trial of Qidong Bufei Decoction in treating postoperative symptoms of non-small cell lung cancernon-small cell lung cancerITMCTR2100004896Guang'anmen Hospital, China Academy of Chinese Medical Sciences.
Recruiting
Phase 2
Homoeopathic treatment of tooth problemsCTRI/2023/03/050348D N De Homoeopathic Medical College and Hospital
Not yet recruiting
Phase 2
The effect of Morus nigra extract on patients with liver cirrhosisiver cirrhosis.Fibrosis and cirrhosis of liverIRCT20140301016776N3Mashhad University of Medical Sciences80
Recruiting
Phase 4
A randomized, double-blind, placebo-controlled clinical trial of Shugan Jieyu Capsule on improving sleep disturbance in New Coronavirus pneumonia during convalescencePatients with sleep mood disorders during recovery from new coronavirus pneumoniaITMCTR2100004389Hubei Hospital of Traditional Chinese Medicine